Months after promising help for “hundreds of thousands of kids,” the FDA approved the decades-old medicine for a disease documented in less than 50 people.

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

The FDA on Tuesday approved leucovorin as a treatment for a rare genetic syndrome, not for autism as the Trump administration had suggested ...

The US FDA approved leucovorin for a rare genetic condition causing cerebral folate deficiency. Though studied as a potential ...

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...

Leucovorin is now indicated for adult and pediatric patients with a confirmed variant in the folate receptor 1 gene, the agency said. This disorder affects fewer than one in 1 million people, with ...

The U. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral ...

NEW YORK – The US Food and Drug Administration on Tuesday approved GSK's Wellcovorin (leucovorin calcium) as a treatment for adult and pediatric patients with cerebral folate deficiency who harbor ...

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who cannot ...

The Food and Drug Administration approved leucovorin, a drug the Trump administration has touted as a potential therapy for autism, to treat cerebral folate transport deficiency, a neurological ...

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...

A study published in Cancer Letters by researchers from the University of Louisville found that a specially designed oral CBD formulation significantly improved tumor targeting and slowed the growth ...